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Human tumour xenografts in a nude rat model have consistently been used as an essential part of preclinical studies for anticancer
drugs activity in human. Commonly, these animals receive whole body irradiation to assure immunosuppression. But whole body
dose delivery might be inhomogeneous and the resulting incomplete bone marrow depletion may modify tumour behaviour.
To improve irradiation-mediated immunosuppression of human non-small cell lung cancer (NSCLC) xenografts in a nude rat
model irradiation (2 + 2 Gy) from opposite sides of animals has been performed using a conventional X-ray tube. The described
modiﬁcation of whole body irradiation improves growth properties of human NSCLC xenografts in a nude rat model. The design
of the whole body irradiation mediated immunosuppression described here for NSCLC xenografts may be useful for research
applications involving other types of human tumours.
1.Introduction
Lung cancer presenting in about 85% by non-small cell
lung cancer (NSCLC) is the leading cause of death among
human malignancies [1]. The ability to establish consistent
human tumour xenografts in small animals is a crucial
part of preclinical NSCLC therapy investigations [2], and
whole body irradiation (WBI) serves as the classic method
for experimentally inducing immunosuppression in rodents
improving tumor take rates for human lung cancer models
in nude mice [3, 4] and nude rats [5–9].
Nevertheless, human tumour xenografts in nude mice
are an accepted model for in vivo biological and preclinical
studies of NSCLC [2–4]. The small size of mice limits their
usefulness in many applications. Rats are often more conve-
nient. They reach 200–400g and are more suitable to some
surgical manipulations, particularly on small structures
such as blood vessels or to molecular imaging applications
especially by means of clinical scanners [10]. At the same
time the size of rats causes an inhomogeneous distribution
of radiation dose due to the absorption of X-rays within
the animal’s body reducing the eﬀectiveness of WBI for
immunosuppression. Decrease of the dose together with
elevated immune competence of nude rats may eﬀects in
substantially diminished tumour take rates compared to
those in nude mice or even spontaneous regression of the
tumours. In this paper a new design of WBI improving
radiation mediated immunosuppression of rats is described
and its application for the generation of human NSCLC
xenografts in nude rat model is discussed. The principles
of human tumour xenograft engraftment in the nude rat
model illustrated here for NSCLC may be useful for research
applications involving other types of human tumours.
2.MaterialandMethods
2.1. Animals. Male athymic 5 weeks old nude rats (Harlan
Laboratories GMbH, Borchen-Alfen, Germany) were kept
ﬁve rats per cage with water and food ad libitum at least one
week before experiments. Animal housing and experiments
were approved by the local animal care committee according
to the institutional guidelines and the German animal wel-
fare regulations. Intraperitoneal anesthesia was performed2 Journal of Biomedicine and Biotechnology
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Figure 1: WBI dose variation in phantoms. Dose distribution along the depth of 6cm ((a), (b)) and 4cm (c) water equivalent phantom for
MonteCarlosimulationoftheX-rayphotonspassagethroughmatter(green)anddoseevaluationusingasetofwaterequivalentplate(1×5×
5cm 3) phantoms phantoms (red) for single (a) and double side ((b), (c)) radiation exposure is presented. The curves have been normalized
to 100% on the surface of phantoms. Corresponding sets of phantoms with noted position of Ionization Chamber are demonstrated (a).
Common (inset A) and new designed (insets B and C) cages with positions of rats during double side irradiation are shown.
with Ketamin 500 (120mg/kg, Curamed, Germany)/Xylazin
(16mg/kg, Rompun, Germany) mixture. Human NSCLC
cells (A549, DSMZ, Braunschweig, Germany) were trans-
planted by subcutaneous injection of 5 × 106 cells in 0.2mL
of phosphate buﬀer saline in the right lower limb of animals
in two days after WBI.
2.2. Radiation Source. Radiation exposure was carried out
by means of the X-ray system (YXLON Int. X-Ray GmbH,
Germany): 200kV, 20mA, 0.5mm Cu.
2.3. Dosimetry. Dosimetry was performed with the clinical
dosimeter UNIDOS equipped with the Semiﬂes Ionization
Chamber (PTW-Freiburg, Germany) using a set of water
equivalent plate (1 × 5 × 5cm 3) phantoms (PTW RW3 Slab
Phantom 29672, Siemens, Germany).
2.4. Software. Dose depth proﬁle within the water equivalent
phantomwascomputedusingGEANT4MonteCarlotoolkit
simulating the passage of X-ray photons through matter. The
simulation results were compared with the measured dose
values.
2.5. Statistics. The experimental results are expressed as
the mean ± standard deviation of several independent
experiments. Analysis of variance (ANOVA) was performed.
3. Results
3.1. Phantom Measurements. The dose depth proﬁle within
the water equivalent phantom computed using the GEANT
4 Monte Carlo toolkit simulating the passage of X-ray
photons through matter was compared with the measured
dose depth values using a set of water equivalent plate (1 ×
5 × 5cm 3)p h a n t o m s( Figure 1). A good agreement in the
dose depth value was revealed between the simulation and
measurements for WBI of rat using common 6 × 6 ×20cm3
cage (Figure 1, inset A). The dose reduces exponentially
from its maximum value (set to 100%) at the top to
∼30% at the bottom of phantom (Figure 1(a)). Therefore,
duringcommonWBI,forexample,with5Gyusingcommon
6 × 6 × 20cm3 cage parts of the rat’s body placed at
the top of the cage could get more than 8Gy, while the
parts located closer to the bottom of the cage including
femur and tibia of the leg, where subcutaneous tumour
transplantation was planned, could receive less then 3Gy.
Thisinhomogeneityofthedosedistributioninthe6cmthick
phantom could be substantially reduced by irradiation from
opposing directions (Figure 1(b)). However, such design of
WBI could not be applied for the rats positioned in the
standard cage due to the movement of the animals during
irradiation time. Even if they had the same position in the
chamber at the beginning of the treatment, they could move
or rotate (Figure 2). It was not possible to follow position of
each rat in time and to calculate the dose received by point of
interest,forexample,atrightlegwheres.c.transplantationofJournal of Biomedicine and Biotechnology 3
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Figure 2: Movement of rats in a common cage. Possible changes
in the position of rats sitting in the common cage during WBI are
presented. Corresponding times are noted in seconds.
tumourcellswasplanned.Therefore,tosolvethisissueanew
cage was designed. Anesthetized rats lying in physiological
position on the right side (Figure 1, inset B) were irradiated
with half of the dose (2Gy), rotated onto the left side
(Figure 1, inset C), and irradiated again with another half of
the dose (2Gy). In this case thickness of rats was less then
4cm, additionally improving the homogeneity of the dose
distribution (Figure 1(c)).
3.2. Tumor Growth. Human NSCLC tumour xenografts in
nude rats were established by subcutaneous injection of 5 ×
106 A549 cells after conventional WBI with dose 5Gy and
afterinducingthenewWBIwithdose2+2Gyfromopposite
sides. In both cases s.c. injection of NSCLC A549 cells
after WBI induced tumour growth in nude rats (Figure 3).
However,afterconventionalWBIwithadoseof5Gytumour
nodules grew relatively slow (Figure 3(A)) and reached a
volume of approximately 60mm3 in 40 days. At the same
time, after double WBI with 2 + 2Gy from opposite sides,
tumour nodules grew signiﬁcantly faster (Figure 3(B)) and
reached a volume of approximately 1000mm3 in 40 days
(Figure 3, inset A).
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Figure 3: Human NSCLC tumour xenograft growth in a nude
rat model. Time dynamics of human NSCLC tumour xenografts
growthestablishedbysubcutaneoustransplantationofA549cellsin
the right leg of the nude rats in 2 days after WBI with dose 5Gy (A)
and after WBI with doses 2 + 2Gy from two sides (B) are presented.
Nodule of about 1000mm3 of volume is shown (inset). Signiﬁcant
diﬀerences (P<. 05) noted by asterisks. Bar is 10mm.
4. Discussion
The presented results show that the conventional X-ray
system could provide acceptable dose uniformity across rats
of typical thicknesses by irradiation of animals (2 + 2Gy)
from opposite sides using a new cage which was created
for irradiation of 2 rats at the same time. An advantage
of the designed WBI for immunosuppression of rats and
improvement of human NSCLC tumour xenograft growth
was illustrated by comparison of two of our attempts to
establish the human NSCLC tumour xenografts in nude rats
after conventional WBI with dose 5Gy and after inducing
the new WBI with dose 2 + 2Gy from opposite sides. In
both cases subcutaneous injection of NSCLC A549 cells after
WBI induced tumour growth. However, after conventional
WBI with a dose of 5Gy tumour nodules grew relatively
slow (Figure 3(A)). We had shown earlier that they achieved
about140mm3 involumein70daysandthenspontaneously
regressed during the following 50 days [6]. At the same
time, after double WBI with 2 + 2Gy from opposite sides,
tumour nodules grew signiﬁcantly faster, reached a volume
of 1000mm3 in 40 days (Figure 3(A)). Resulted tumours
werelargeenoughtobesuccessfullyinvestigatedbymagnetic
resonance imaging, positron emission tomography, and
computed tomography using clinical scanners [7]. Subse-
quent investigations of the same human NSCLC tumour
xenografts in nude rat model have shown that manipulation
of tumour xenograft environment could further enhance
tumour growth and change tumour vascularisation by
administration of exogenous growth factors, cotransplanta-
tion with endothelial cells or modiﬁed by additional tumour
bed irradiation [8, 9].4 Journal of Biomedicine and Biotechnology
Nevertheless, the reported method of double WBI from
two opposite sides can be applied using commercially
availableX-raytubes;increasedhomogeneityoftheradiation
dose distribution through the cross section of the animal’s
body, allowing for producing human NSCLC xenografts
by subcutaneous injection of A549 cells in the leg of the
nude rat, yields reliable tumour growth patterns. Established
human tumour xenografts were suitable for analysis in clin-
ical scanners, oﬀered good image quality, and presented an
alternative to dedicated small animal scanners for numerous
applications in cancer research [10]. Presenting method
of radiation mediated immunosuppression of rats may be
useful for many preclinical research applications involving
other types of human tumours.
Abbreviations
NSCLC: Non-small cell lung cancer
WBI: whole body irradiation.
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